Patients in England with aggressive head and neck cancers will be fast-tracked into a new cancer vaccine trial.
Professor Peter Johnson, the National Clinical Director for Cancer for NHS England says the new mRNA vaccine will ''flag up the cancer more effectively”.
Report by Gluszczykm.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
